Breast cancer, vaccine

Breast cancer vaccine update from Cleveland Clinic: ‘A new era’
A breast cancer vaccine could be closer to reality, according to Cleveland Clinic, as its researchers have announced some encouraging results. Researchers and doctors weigh in.
New therapeutic vaccine gives hope against an aggressive breast cancer
An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.
A Clinical Trial Found an Effective Vaccine for Aggressive Breast Cancer
An experimental vaccine teaching patients’ immune systems to identify and attack cancer cells could help women diagnosed with triple-negative breast cancer.
What Are The Most Effective Treatments For Stage 4 Breast Cancer?
While stage 4 breast cancer is challenging, there are several effective treatment options available that can help manage the disease and improve quality of life.
Hope for Patients with Aggressive Breast Cancer: Vaccine Trial Results in 88% Survival Rate After 3 Years
After surgery, the team analyzed and compared the tumor tissue with the healthy tissue of the same patient to find unique genetic mutations
New vaccine shows promise for patients with aggressive breast cancer
An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.
New vaccine designed to target triple-negative breast cancer
A new vaccine is offering hope for people fighting an aggressive form of breast cancer. Dr. Michael Daignault talks about this vaccine as well as other medical news.
New vaccine shows promise in treating aggressive form of breast cancer
Breast cancer patients have been given fresh hope after a new vaccine showed "promise" in treating an aggressive form of the disease. The results came in a clinical trial involving American patients with triple-negative breast cancer who received an experimental jab designed to prevent the recurrence of tumors.
Neoantigen DNA Vaccines Safe, Induce Response in Triple-Negative Breast Cancer
Neoantigen DNA vaccines are safe and capable of inducing neoantigen-specific immune responses in patients with triple-negative breast cancer, according to a study published online Nov. 14 in Genome Medicine.
Breast cancer hope as vaccine shows “promising” results
Breast cancer patients have been given fresh hope after a new vaccine showed “promise” in treating an aggressive form of the disease. The results came in a clinical trial involving American patients with triple-negative breast cancer who received an experimental jab designed to prevent the recurrence of tumours.
News Medical10h
Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients
A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...
TheHealthSite3d
Breast Cancer Treatment In Pregnant Women: Is It Safe For The Foetus?
While breast cancer is rare in pregnant women, if detected, its treatment does not affect the foetus in any manner. The ...
Brainerd Dispatch3d
Shorter, less intense radiation treatment for breast cancer has benefits, Mayo Clinic study finds
A Mayo Clinic research team tested a shorter radiation treatment plan on breast cancer patients. The abbreviated treatment ...
Woman, 53, Recalls Family ‘Ghosting’ Her After Cancer Diagnosis, Being Alone During Treatment: ‘Punch to the Gut’
Ashley Levinson opened up about how difficult it was when two of her close family members ghosted her after she revealed that ...
STAT11d
Tattoo-less radiation treatment is the future of cancer care
The experience of breast cancer patients highlights the emotional toll these tattoos can take. Traditionally, these ...
Daily Cardinal4d
Breast cancer awareness must last beyond one month of the year
As breast cancer awareness month concludes, I want to remind you that awareness and advocacy should not be limited to just ...
The Washington Post4d
A scientist experimented on herself to treat her cancer. It worked.
Halassy’s breast cancer had returned twice after her 2016 diagnosis. After the viral treatment, she has been cancer-free for 45 months, the study says. With the experiment, Halassy joins a ...